openPR Logo
Press release

Lawsuit filed for Investors in NASDAQ: HSDT shares against Helius Medical Technologies, Inc.

07-29-2019 10:35 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares.

A lawsuit was filed on behalf of investors in Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares.

An investor, who purchased shares of Helius Medical Technologies, Inc. (NASDAQ: HSDT), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Helius Medical Technologies, Inc.

Investors who purchased shares of Helius Medical Technologies, Inc. (NASDAQ: HSDT) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On January 22, 2019, an article was published stating that Helius Medical Technologies’ phase III trial “missed its primary effectiveness endpoint” and that Helius “has redacted important trial info.” The article further states that the founders “have a history of questionable marketing practices” and that the former CEO “is now a fugitive.”

On April 10, 2019, Helius Medical Technologies’ disclosed that the U.S. Food and Drug Administration ("FDA") had declined the Company's request for De Novo classification and clearance of its Portable Neuromodulation Stimulator device. The FDA stated that it lacked sufficient data to determine the relative contributions of the device and physical therapy in clinical studies
Shares of Helius Medical Technologies, Inc. (NASDAQ: HSDT) declined from $17.97 per share in October 2017 to as low as $1.77 per share on April 11, 2019.

According to the complaint the plaintiff alleges on behalf of purchasers of Helius Medical Technologies, Inc. (NASDAQ: HSDT) common shares between November 9, 2017 and April 10, 2019, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 9, 2017 and April 10, 2019, the Defendants failed to disclose to investors: (1) that the clinical study on the use of PoNS did not produce statistically significant results regarding the effectiveness of the treatment; (2) that, as a result, the clinical study did not support the Company’s application for regulatory clearance; (3) that, as a result, the Company was unlikely to receive regulatory approval of PoNS; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Helius Medical Technologies, Inc. (NASDAQ: HSDT) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in NASDAQ: HSDT shares against Helius Medical Technologies, Inc. here

News-ID: 1813847 • Views: 212

More Releases from Shareholders Foundation

Investigation announced for NYSE: COF Investors over possible Wrongdoing at Capi …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Capital One Financial Corporation. Investors who are current long term investors in Capital One Financial Corporation (NYSE: COF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: COF stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Acadia Healthcare Company Inc …
An investigation was announced for investors in shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) concerning potential breaches of fiduciary duties by certain directors at Acadia Healthcare Company Inc. Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) and currently hold any of those NASDAQ: ACHC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
Investigation for Investors in shares of PlayAGS, Inc. (NYSE: AGS) announced
An investigation was announced concerning potential securities laws violations by PlayAGS, Inc. in connection with certain financial statements. Investors who purchased shares of PlayAGS, Inc. (NYSE: AGS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of PlayAGS, Inc. (NYSE: AGS) concerning whether a series of statements
Lawsuit filed for Investors in shares of Spirit AeroSystems Holdings, Inc. (NYSE …
An investor, who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE: SPR), filed a lawsuit over alleged violations of Federal Securities Laws by Spirit AeroSystems Holdings, Inc. Investors who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE: SPR) have certain options and for certain investors are short and strict deadlines running. Deadline: April 10, 2020. NYSE: SPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Helius

Biomass Pellets Market to Witness Huge Growth | MGT Power , Energex, Helius Ener …
A new research document is added in HTF MI database of 105 pages, titled as 'Global Biomass Pellets Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America,South America , Asia Pacific, Europe,MEA and important players/vendors such as Bio-bean, Helius Energy (U.K.) , MGT Power (U.K.) , Energex,
Global Neurorehabilitation Devices Market to 2025| Medtronic PLC, Agiliad, Alter …
Albany, NY, 8th January : Recent research and the current scenario as well as future market potential of "Global Neurorehabilitation Devices Market Insights, Forecast to 2025" globally. This report studies the global market size of Neurorehabilitation Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurorehabilitation Devices in these regions. This research report categorizes the global Neurorehabilitation
Neurorehabilitation Devices Global Market 2018 Analysis By Key Players – Medtr …
Summary WiseGuyReports.com adds “Neurorehabilitation Devices Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database. This report provides in depth study of “Neurorehabilitation Devices Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Neurorehabilitation Devices Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as
Helius Medical Technologies Inc (HSM) Market: Industry Size, Share, Growth, Fore …
Latest industry research report on: Global Helius Medical Technologies Inc Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brains ability to heal itself. It offers development of technologies as a potential treatment for neurological symptoms caused
Global Biomass Power Generation Market 2017 - Drax Group, Forth Energy Ltd., Hel …
The Global Biomass Power Generation Market 2017 Research Report includes a complete and meticulous study of Biomass Power Generation industry covering different aspects like market volume, market Share, market strategies, Biomass Power Generation growth trends, variety of applications, utilization volume, demand and supply analysis, production capacity and Biomass Power Generation industry cost structures during Forecast period from 2017 to 2022. The report titled Global Biomass Power Generation Market 2017 provides the
Global Biomass Power Generation Market 2017 - Ameresco, Alstom, Drax Group, Heli …
The report studies Biomass Power Generation in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The Global Biomass Power Generation Industry report delivers en executive-level blueprint of the Biomass Power Generation market that will help clients to build strategies to expand their market operations. The report on the Global Biomass